Come and join us across the globe
Sign In

NEWS

PRESS RELEASE

Phenox Announces Exclusive Distribution Agreement with Wallaby Medical I...

Phenox is pleased to announce that it has signed an exclusive distribution agreement with Wallaby Medical Inc. for commercialization of The Avenir™ Detachable Coil System in the U.S. and EU markets.

PRESS RELEASE

Wallaby Medical Inc. announces CE Mark and FDA Clearance of the Avenir™...

Wallaby Medical announces CE Mark approval and FDA 510(k) clearance of its differentiated embolic coil system, the Avenir Coil System. The intended use for the Avenir Coil System is for endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae. The Avenir Coil System is also intended for arterial and venous embolization in the peripheral vasculature.

PRESS RELEASE

1st Pass Success with NeVa™ "M1S" (4.0 x 22 mm) after failure of 2 diffe...

Watch this clinical case report from a 75 year old female patient presented with NIHSS of 19 presented 4 hours after symptom onset.It was noted that the patient had had a knee implant surgery 3 days prior to her stroke. Additional risk factors included: Coronary Heart Failure, Hypertension, Diabetes, Atrial fibrillation.On admission CT ASPECTS was 10.Imaging confirmed distal left MCA occlusion.

PRESS RELEASE

Medtronic Partners with Viz.ai to Accelerate Adoption of New Artificial...

DUBLIN and SAN FRANCISCO, July 22, 2019 (GLOBE NEWSWIRE) - Medtronic plc (NYSE:MDT), a global leader in medical technology, and Viz.ai, the emerging leader in applied artificial intelligence (AI) in stroke care, have partnered to accelerate the adoption of Viz.ai’s new technology, which helps synchronize stroke care and decrease time to treatment, potentially improving outcomes for patients.

Come and join us across the globe